全文获取类型
收费全文 | 1779364篇 |
免费 | 138205篇 |
国内免费 | 3003篇 |
专业分类
耳鼻咽喉 | 24277篇 |
儿科学 | 59896篇 |
妇产科学 | 51784篇 |
基础医学 | 251280篇 |
口腔科学 | 53298篇 |
临床医学 | 155387篇 |
内科学 | 345146篇 |
皮肤病学 | 38277篇 |
神经病学 | 141754篇 |
特种医学 | 74241篇 |
外国民族医学 | 566篇 |
外科学 | 271097篇 |
综合类 | 40746篇 |
现状与发展 | 3篇 |
一般理论 | 547篇 |
预防医学 | 138159篇 |
眼科学 | 40546篇 |
药学 | 133837篇 |
4篇 | |
中国医学 | 3109篇 |
肿瘤学 | 96618篇 |
出版年
2018年 | 18452篇 |
2017年 | 15648篇 |
2016年 | 16186篇 |
2015年 | 19776篇 |
2014年 | 24920篇 |
2013年 | 35254篇 |
2012年 | 52150篇 |
2011年 | 49883篇 |
2010年 | 28891篇 |
2009年 | 29310篇 |
2008年 | 45717篇 |
2007年 | 48699篇 |
2006年 | 49717篇 |
2005年 | 55744篇 |
2004年 | 56448篇 |
2003年 | 50343篇 |
2002年 | 45066篇 |
2001年 | 79511篇 |
2000年 | 80262篇 |
1999年 | 71065篇 |
1998年 | 18440篇 |
1997年 | 16801篇 |
1996年 | 16796篇 |
1995年 | 16525篇 |
1994年 | 15535篇 |
1993年 | 14609篇 |
1992年 | 60859篇 |
1991年 | 59431篇 |
1990年 | 58492篇 |
1989年 | 56412篇 |
1988年 | 52469篇 |
1987年 | 51722篇 |
1986年 | 49237篇 |
1985年 | 47251篇 |
1984年 | 35099篇 |
1983年 | 30056篇 |
1982年 | 17029篇 |
1981年 | 15114篇 |
1979年 | 33701篇 |
1978年 | 23116篇 |
1977年 | 19246篇 |
1976年 | 18043篇 |
1975年 | 19694篇 |
1974年 | 24156篇 |
1973年 | 23033篇 |
1972年 | 21278篇 |
1971年 | 20188篇 |
1970年 | 18556篇 |
1969年 | 17454篇 |
1968年 | 15951篇 |
排序方式: 共有10000条查询结果,搜索用时 281 毫秒
51.
Ki-Yong An Andria R. Morielli Dong-Woo Kang Christine M. Friedenreich Donald C. McKenzie Karen Gelmon John R. Mackey Robert D. Reid Kerry S. Courneya 《International journal of cancer. Journal international du cancer》2020,146(1):150-160
The Combined Aerobic and Resistance Exercise (CARE) Trial compared different types and doses of exercise performed during breast cancer chemotherapy. Here, we report the longer-term follow-up of patient-reported outcomes, health-related fitness and exercise behavior at 6, 12 and 24 months postintervention. A multicenter trial in Canada randomized 301 breast cancer patients initiating chemotherapy to thrice weekly, supervised exercise consisting of a standard dose of 25–30 min of aerobic exercise (STAN; n = 96), a higher dose of 50–60 min of aerobic exercise (HIGH; n = 101) or a combined dose of 50–60 min of aerobic and resistance exercise (COMB; n = 104) performed for the duration of chemotherapy (median of 17 weeks). Primary outcomes were patient-reported outcomes including quality of life, cancer-related symptoms and psychosocial outcomes. Secondary outcomes were objective health-related fitness (assessed at 12 months only) and self-reported exercise behavior. A total of 269 (89.4%) participants completed patient-reported outcomes at all three follow-up time points and 263 (87.4%) completed the health-related fitness assessment at 12-month follow-up. COMB was significantly superior to (i) STAN for sleep quality at 6-month follow-up (p = 0.027); (ii) HIGH for upper body muscular endurance at 12-month follow-up (p = 0.020); and (iii) HIGH for meeting the resistance exercise guideline at 6-month follow-up (p = 0.006). Moreover, self-reported meeting of the combined exercise guideline during follow-up was significantly associated with better patient-reported outcomes and health-related fitness. Performing combined exercise during and after breast cancer chemotherapy may result in better longer-term patient-reported outcomes and health-related fitness compared to performing aerobic exercise alone. 相似文献
52.
53.
Y.R. Song B. Wu Y.T. Yang J. Chen L.J. Zhang Z.W. Zhang H.Y. Shi C.L. Huang J.X. Pan P. Xie 《Brazilian journal of medical and biological research》2015,48(11):973-982
Bipolar disorder (BD) is a common psychiatric mood disorder affecting more than 1-2%
of the general population of different European countries. Unfortunately, there is no
objective laboratory-based test to aid BD diagnosis or monitor its progression, and
little is known about the molecular basis of BD. Here, we performed a comparative
proteomic study to identify differentially expressed plasma proteins in various BD
mood states (depressed BD, manic BD, and euthymic BD) relative to healthy controls. A
total of 10 euthymic BD, 20 depressed BD, 15 manic BD, and 20 demographically matched
healthy control subjects were recruited. Seven high-abundance proteins were
immunodepleted in plasma samples from the 4 experimental groups, which were then
subjected to proteome-wide expression profiling by two-dimensional electrophoresis
and matrix-assisted laser desorption/ionization-time-of-flight/time-of-flight tandem
mass spectrometry. Proteomic results were validated by immunoblotting and
bioinformatically analyzed using MetaCore. From a total of 32 proteins identified
with 1.5-fold changes in expression compared with healthy controls, 16 proteins were
perturbed in BD independent of mood state, while 16 proteins were specifically
associated with particular BD mood states. Two mood-independent differential
proteins, apolipoprotein (Apo) A1 and Apo L1, suggest that BD pathophysiology may be
associated with early perturbations in lipid metabolism. Moreover, down-regulation of
one mood-dependent protein, carbonic anhydrase 1 (CA-1), suggests it may be involved
in the pathophysiology of depressive episodes in BD. Thus, BD pathophysiology may be
associated with early perturbations in lipid metabolism that are independent of mood
state, while CA-1 may be involved in the pathophysiology of depressive episodes. 相似文献
54.
Improvement in Tricuspid Annular Plane Systolic Excursion with Pulmonary Hypertension Therapy in Pediatric Patients 下载免费PDF全文
55.
56.
57.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献58.
59.
60.